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ABSTRACT

People with lung cancer are at a high risk of developing anxiety and depression during
cancer treatments. Previous research has shown physical activity to be effective in improving
psychological symptoms in people with cancer, however, the majority of studies have focused on
female breast cancer survivors. The purpose of this literature review was to determine if physical
activity interventions can effectively and feasibly reduce anxiety and depression in people with
lung cancer who are undergoing treatment. A database search was conducted in CINAHL Plus,
MEDLINE, APA PsycInfo, and SPORTDiscus. The search resulted in 265 articles and 9 were
selected for inclusion in this review. Four studies showed significant improvements in anxiety
and depression, six studies showed significant improvements in only anxiety, and the remaining
studies showed no effect. The studies that improved both anxiety and depression used
multimodal physical activity programs that included the use of supplemental psychological and
health promoting interventions. Limitations included high drop-out rates, small sample sizes, and
using different physical activity programs in a portion of the studies. Multimodal physical
activity programs are safe and feasible and should be recommended to reduce anxiety and
depressions in people with lung cancer undergoing treatment.
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BACKGROUND

The Centers for Disease Control and Prevention (CDC) (2019) states that lung cancer is
the leading cause of cancer related deaths in the United States for both men and women and is
accountable for nearly 20% of total cancer deaths worldwide (Carnio et al., 2016). By the time of
diagnosis of lung cancer, more than 70% of patients are inoperable (Quist et al., 2020). The fiveyear survival rate for people with lung cancer is around 16-20%, with only an average life
expectancy of 10-15 months for people diagnosed with advanced inoperable lung cancer (Quist
et al., 2020). Another study states that only 10.9% of people diagnosed with lung cancer live
more than five years (Carnio et al., 2016). However, Chen et al. (2015) state that the number of
lung cancer survivors are increasing worldwide.
Common treatment options seen with lung cancer include several types of surgery,
radiation therapy, chemotherapy, stereotactic body radiotherapy, targeted drug therapy, and
immunotherapy (Mayo Clinic, 2020). All of these treatment options can cause numerous side
effects, including but not limited to cardiac toxicities, long-term neuropathy, hearing loss,
anxiety, and depression (Johns Hopkins Medicine, n.d.). Of these symptoms, psychological
problems such as anxiety and depression are frequently experienced among people with lung
cancer (Chen et al., 2015). Around 44% of people with lung cancer suffer from depression and
anxiety, which is noted to be consistently higher than other cancer types, and the psychological
effects of these symptoms have been shown to negatively affect anticancer treatment and
mortality (Quist et al., 2020). Chen et al. (2015) report anxiety being present in one-third of
people with lung cancer, and another study reports depression being observed in nearly one-third
of patients as well (Henshall et al., 2019). Brown et al. (2014) report that lung cancer patients
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experience the highest levels of psychological distress among 14 different cancer diagnoses.
They state that lung cancer patients are at high risk for developing or worsening psychosocial
problems during and after treatment, and that one study reported anxiety and depression nearly
doubled after three months from the time of diagnosis for people with lung cancer (Brown et al.,
2014). These studies show that anxiety and depression are very prevalent in lung cancer and that
many patients suffer from these symptoms.
Quist et al. (2020) state that patients suffer psychologically throughout the course of the
disease from the symptoms, co-morbidities, and side effects of treatment of the disease with
patients mainly fearing losing function and their independence. Henshall et al. (2019) also state
that depression and anxiety in people with lung cancer can arise and worsen from multiple
modalities, including surgery, radiotherapy, and/or chemotherapy. Aside from common
treatment options playing a role in increasing depression and anxiety levels (Brown et al., 2014),
lung cancer stigma (LCS) also contributes to the high distress levels in lung cancer patients. LCS
is a perceived health stigma that comes from the negative perceptions about the relationship
between smoking and lung cancer, and previous research has shown LCS to be associated with
higher depression and anxiety levels, regardless of the patient’s smoking status (Brown et al.,
2014).
Treatment and recognition of anxiety and depression in people with lung cancer is
important because anxiety and/or depression can have profound effects on survivor’s emotional
and physical well-being, which in turn can interfere with their activities of daily living (Henshall
et al., 2019). Chen et al. (2015) recognize that anxiety, depression, and cancer-related symptoms
may impair a person’s quality of life (QoL) and functional ability in lung cancer survivors.
Brown et al. (2014) state that depression and anxiety specifically are associated with a decreased
2

QoL in people with lung cancer. A study published by Vodermaier et al. (2017) found that
people who experience anxiety and depression after being diagnosed with advanced lung cancer
are more likely to die sooner than people who report not having anxiety or depression. Previous
research supports this, as it suggests an association between a patient’s higher reported QoL at
the time of diagnosis and an increased life span (Brown et al., 2014).
Treating anxiety, depression, or both symptoms can be done using multiple different
interventions, a lot of which are also used for treating the general public. One intervention used
worldwide, not just for oncology patients but for anyone experiencing either of these symptoms,
is the use of pharmaceuticals. In 2017, the National Center for Health Statistics reported that
12.7% of the U.S. population over the age of 12 took antidepressant medication in the past
month (Winerman, 2017). According to the 2013 Medical Expenditure Panel Survey (MEPS),
around 1 in 6 Americans currently took a psychiatric drug, also confirming that 12 percent of
adults were taking an antidepressant medication (Anxiety and Depression Association of
America (ADAA), 2019). One study indicated that cancer survivors in the United States use
medication for anxiety and depression more frequently than the general public (Hawkins et al.,
2016). Responses from the National Health Interview Survey between the years 2010 to 2013
indicated that nearly 19% of cancer survivors take medication for anxiety and/or depression, with
previous research finding that 31% of survivors sought help for psychological concerns
(Hawkins et al., 2016).
Pharmaceuticals have been shown to be effective when treating anxiety and depression in
people with lung cancer (Begley, 2016). A study conducted by Zingone et al. (2017) reported
that antidepressants such as norepinephrine-dopamine reuptake inhibitors (NDRIs) and tricyclic
antidepressants (TCAs) were associated with improved survival rates for people with lung cancer
3

who took them for conditions including depression and/or anxiety. Zingone et al. (2017) state
that these are feasible adjunct therapeutics for people with lung cancer due to the low cost of
these drugs and tolerable side effects. However, while this can be a convenient intervention for
some people, others may experience unwanted and harmful side effects (Begley, 2016). Zingone
et al. (2017) also reported that a phase IIA clinical trial targeting stage IV small cell lung cancer
patients with a TCA had ended due to most of the patients having intolerable side effects to the
medication. This data suggests that treating anxiety and depression with pharmaceuticals may
not be the best option for every person who has lung cancer.
Luckily, there are non-pharmaceutical interventions that exist to help treat anxiety and
depression that can be used in people with lung cancer. Common non-pharmaceutical treatment
options used that have shown to be effective in improving mood in cancer survivors include
cognitive behavioral therapy, hypnosis, self-management strategies, and physical activity (Yi &
Syrjala, 2017). While evidence from randomized controlled trials indicates all of these
interventions being effective in improving psychological symptoms, the majority of studies have
focused on female breast cancer survivors (Yi & Syrjala, 2017). Further research is needed to
determine the effectiveness and feasibility of using these interventions in people with different
types of cancers, such as lung cancer, that include all genders.
One non-pharmaceutical intervention that has been studied is the use of physical activity
in people with lung cancer to reduce psychological symptoms such as anxiety and depression.
Physical activity such as exercise has been universally accepted as being beneficial to one’s
health (Medline Plus, 2020). A few benefits that result from exercise in general population
include helping control body weight, reducing risk for heart disease, strengthening bones and
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muscles, improving sleep, increasing chances of living longer, reducing risks of some cancer
including lung cancer, and improving mental health and mood (Medline Plus, 2020).
Studies have shown that physical activity interventions reduce depression and anxiety
effectively in cancers such as breast cancer (Yi & Syrjala, 2017). There are randomized
controlled trials that have also suggested physical activity interventions to be effective on
reducing these symptoms, specifically in people with lung cancer. These studies have been
conducted in many different patient populations, however, many of these studies have a small
sample size, may contain bias, and all use different physical activity interventions (Quist et al.,
2020). This leads to an uncertainty of which physical activity interventions are actually effective,
which ones are the most effective, and which interventions are feasible for nurses to recommend
to patients. Wang et al. (2019) encourage recommending home-based exercise programs as
treatment but suggest further research to determine the most effective physical activity
interventions for improving psychological symptoms.

5

PURPOSE

The primary purpose of this literature review was to determine if physical activity
interventions can effectively reduce depression and anxiety in people with lung cancer
undergoing treatment. The secondary aim of this literature review was to determine the
feasibility of prescribing physical activity interventions to reduce anxiety and depression. It must
be determined if patients are capable and willing to adhere to the recommended interventions,
and if it is practical for nurses to recommend these interventions to people with lung cancer.

6

METHODS

A review of the literature was conducted to determine if physical activity interventions
are effective in reducing anxiety and depression in people with lung cancer undergoing
treatment. The databases used to find articles included CINAHL, APA PsycInfo, MEDLINE, and
SPORTDiscus databases. The search for articles took place between June 2020 and October
2020. Key terms used in the search included “TI cancer* or AB cancer* or SU cancer or (MH
"Cancer Patients") OR (MH "Neoplasms")”, AND “exercis* or ‘physical activity’”, AND
“depression or depressive or anxiety”, AND “lung.” Studies met inclusion criteria for the review
if they included lung cancer survivors currently undergoing radiation therapy, chemotherapy,
targeted drug therapy, immunotherapy, and/or surgery. Studies were excluded if they were not
published in English, were published before 2010, if the patients in the study were receiving
palliative care, and if any of the patients were under 18 years old.
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RESULTS

An initial search resulted in 265 articles: MEDLINE (120), CINAHL Plus with Full Text
(97), APA PsycInfo (34), and SPORTDiscus (14). After the removal of duplicates, carefully
reviewing the title, abstract, and/or full text of the remaining articles, 256 were excluded because
they did not meet the inclusion criteria. Nine articles were selected for inclusion in this review.
Figure 1 shows the selection process for the literature review.
The characteristics of each study are listed in Table 1. Five studies were conducted on
patients only receiving chemotherapy (Arai et al., 2010; Olivier et al., 2018; Park et al., 2019;
Quist et al., 2015; Quist et al., 2020), one study included patients receiving chemotherapy and/or
radiotherapy (Kuehr et al., 2014), two studies included patients who received recent surgery
directly related to lung cancer and also receiving chemotherapy (Cavalheri et al., 2017, Sommer
et al., 2018), and one study included patients who had received surgery directly related to lung
cancer without any current adjuvant therapies (Lu et al., 2020).
The effects of a physical activity (PA) program on people with anxiety and depression
undergoing treatment were assessed in eight of the studies (Arai et al., 2010; Cavalheri et al.,
2017; Lu et al., 2020; Park et al., 2019; Olivier et al., 2018; Quist et al., 2015; Quist et al., 2020;
Sommer et al., 2018), while the study by Kuehr and colleagues (2014) only assessed depression.
The HADS tool was used to measure anxiety and depression in six studies (Arai et al., 2010;
Cavalheri et al., 2017; Olivier et al., 2018; Quist et al., 2015; Quist et al., 2020; Sommer et al.,
2018). The PHQ-9 measurement tool was used in two studies to measure depression (Kuehr et
al., Park et al., 2019), the GAD-7 tool was used in one study to measure anxiety (Park et al.,
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2019), and the SAS and SAD tools were used to measure anxiety and depression in one study
(Lu et al., 2020).
Six of the articles used a pretest-posttest cohort study design (Arai et al., 2010; Kuehr et
al., 2014; Lu et al., 2020; Olivier et al., 2018; Park et al., 2019; Quist et al., 2015), two studies
used a randomized controlled trial comparative study design (Cavalheri et al., 2017; Quist et al.,
2020) and one study used a 4-arm, randomized feasibility design (Sommer et al., 2018). Sample
sizes for the studies ranged from 9 to 218 participants. The mean ages of participant’s ranged
from 55.1 to 68 years old. Diagnosis’ of the participant’s lung cancers ranged from stage I-IV.
One study implemented an intervention that included information and encouragement
about PA without a specific exercise program in place (Arai et al., 2010), two of the studies
implemented an intervention consisting of exercise-only programs (Cavalheri et al., 2017; Kuehr
et al., 2014), and six of the studies implemented multiple interventions that included an exercise
program with additional non-exercise interventions (Lu et al., 2020; Olivier et al., 2018; Park et
al., 2019; Quist et al., 2015; Quist et al., 2020; Sommer et al., 2018).
The length of the programs varied among the studies, as four studies were 12 weeks in
length (Lu et al., 2020; Park et al., 2019; Quist et al., 2020; Sommer et al., 2018), three studies
were eight weeks in length (Cavalheri et al., 2017; Kuehr et al., 2014; Olivier et al., 2018), one
study was six weeks (Quist et al., 2015), and the last study was four weeks (Arai et al., 2010).
Four of the studies conducted supervised PA programs (Cavalheri et al., 2017; Quist et al., 2015;
Quist et al., 2020; Sommer et al., 2018), two of the studies used a combination of supervised and
unsupervised PA programs (Kuehr et al., 2014; Lu et al., 2020), and three of the studies
implemented an unsupervised PA program (Arai et al., 2010; Olivier et al., 2018; Park et al.,
2019).
9

Figure 1
Prisma Flow Diagram

Records identified by database searching (n=265)

Records after removal of
duplicates (n=156)

Records after screening with
parameters (n=119)
(Written in English, newer than
10 years)

Record’s titles and abstracts
screened (n=119)

Records excluded based on
titles and abstracts (n=70)

Full-text articles assessed for
eligibility (n=49)

Articles excluded. Reasons for
Exclusions:
(n=15, literature reviews)
(n=9, no PA intervention)
(n=9, trial protocols)
(n=5, patients not undergoing
treatment)
(n=1, no specific results on LC
patients)
(n=1, no results on anxiety and/or
depression)

Studies included in the review
(n=9)
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FINDINGS

The results of each study and details of each intervention are described below. Findings
listed include the effects of PA on anxiety and depression, and any other significant findings that
the researchers were measuring for each study. Interventions used in the studies alongside PA
interventions are included as well.
Encouragement and Supportive PA Interventions
The study by Arai and colleagues (2010) examined the feasibility of an intervention
aimed to increase PA levels and to measure psychological adjustment in advanced LC patients.
The researchers implemented an intervention that provided support and encouragement through a
4-week period that aimed to enhance participant’s PA levels. Participants (n=9) wore a step
counter throughout the day which tracked their activity levels. Each patient was instructed to live
normally for one week, then the intervention was provided to each participant to enhance their
PA the following week (start of week 1 – T1, end of week 1 – T2). The intervention included
feedback, positive reinforcement, enhancement of autonomy, and information for setting goals
relating to PA. This occurred again after week 2 (T3), and again after week 4 (T4). Outcomes
including anxiety and depression were compared with step counts throughout the study to
observe for any correlation between the two. No significant changes were noted throughout the
study in mean step counts, anxiety scores, or depression scores. Higher step counts did have a
significant relationship with lower depression scores in the beginning of the intervention at week
1 (T2) and week 2 (T3) but had no correlation after this. The researchers state that this indicates
a relationship between PA and psychological adjustment and a successful PA intervention design
11

are possible. Three participants dropped out of the study by the end of the second week (33.3%
dropout rate). The researchers suggest that a PA intervention program is not feasible for LC
patients undergoing chemotherapy based on their results.
Endurance and Strength PA Interventions
Two studies implemented exercise only interventions and both used an 8-week endurance
and strength exercise program (Cavalheri et al., 2017; Kuehr et al., 2014). The first was A
randomized clinical trial (RCT) by Cavalheri and colleagues (2017) examining the correlation
between supervised exercise training and exercise capacity, PA levels, peripheral muscle force,
lung function, and psychological reportings from patients. The 8-week exercise program engaged
participants in supervised, individualized training three times per week for 60 minutes. Each
session consisted of aerobic (walking or cycling) and resistance (upper and lower limbs) training.
Participants in the exercise group (EG) (n=9) walked in a corridor or on a treadmill for 20
minutes at an intensity of 70%-80% of their maximum effort. The resistance training consisted of
step-ups (2 sets of 10 repetitions) and exercises with weights for the upper arms (3 sets of 10
repetitions). The control group (CG) (n=8) was instructed to continue to perform their usual
activities. They received phone calls once a week, consisting of general conversation and
standardized questions about their well-being. It is unclear if the intervention group received
these phone calls as well. Anxiety scores and depression scores were compared between the EG
and CG. Anxiety scores and depression scores showed no significant changes post-intervention,
although there was a significant increase in exercise capacity for the exercise group: oxygen
consumption (p=0.02) and 6-minute walk distance (p=0.02). Four of the nine participants (44%)
completed at least 15 (60%) of the training sessions (mean 17 ± 3). The researchers suggest that
LC patients may benefit from PA programs.
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The other study was a cohort study by Kuehr and colleagues (2014) aimed at determining
the feasibility of an exercise program and assessing if there was a correlation between exercise
and strength capacity, QoL, fatigue, and depression. The intervention was an 8-week consecutive
hospital and home-based exercise program, combining endurance and resistance training. All
patients (n=40) received exercise materials and a training manual and recorded their exercises in
a standardized diary. During the inpatient setting, participants exercised five times a week, with
three of the days being supervised, and two of the days being independent training sessions. At
home, participants exercsied three times a week. Endurance training included brisk walks or a
cycle ergometer during inpatient stays, and resistance training exercises were performed
following a training manual. In addition, participants received a follow up phone call each week
so they could report any problems or difficulties with the interventions. Outcomes were
measured at baseline (T0), post-intervention (T1), and at 8 weeks post-intervention (T2). The
researchers concluded this as a feasible PA program, as twenty-two (55%) of the 40 participants
met feasibility requirements of performing at least two training sessions per week in six of the
eight intervention weeks. The dropout rate of participants was 23%. Depression scores had no
significant change over time, however, depression scores actually increased slightly from T0 to
T1 (T0: 5.4 ± 3.8; T1: 6.0 ± 4.6), but this was not statistically significant and declined by T2 (T2:
4.7 ± 3.6). There was a significant improvement in functional capacity, including increased
strength in knee extension and flexion (p<0.01), hip abduction (p<0.01), and endurance (28 m;
p<0.01).
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Multimodal Pulmonary Rehabilitation Interventions
Two of the studies implemented pulmonary rehabilitation (PR) programs while also
offering education and counseling. (Olivier et al., 2018; Park et al., 2019). The cohort study by
Olivier and colleagues (2018) aimed to assess the feasibility of a home-based pulmonary
rehabilitation (PR) program and to evaluate safety and effectiveness of the intervention in LC
and mesothelioma patients receiving chemotherapy. In this 8-week, home-based PR program,
participants exercised five days a week for 30-45 minutes a day. The training programs were
individually tailored to participants, involving endurance training on the cycle ergometer,
strength developing exercises using weights and resistance bands, and incorporating activities of
daily living. At the end of each week, a member of the rehabilitation team provided follow-up
care to each patient for 90 minutes. These sessions included feedback and information on
exercise training, information on resuming daily living activities, therapeutic education,
psychological counseling, motivational communication, and advice on nutrition to aid in healthy
behavior and self-management. Of the 243 potential participants eligible for participation, 65.8%
refused to enroll. Once patients enrolled, 11 more dropped out, leaving 71 patients who started
the intervention. Twenty-four additional participants dropped out before the end of the PR
program, leaving only 47 patients who finished the program. The researchers considered this
program feasible and safe. There was a significant decrease in anxiety scores by the end of the
program (Before PR: 7 [5-10], After PR: 6 [3-8], p=0.03), however, there was no significant
decrease in depression scores. Daily PA scores (p=0.007), the 6-minute stepper count (p=0.02),
and the time needed to complete 10 chair stands (10CS) (p=0.04) significantly improved in LC
patients as well.

14

The cohort study by Park and colleagues (2019) evaluated the feasibility and efficacy of a
12-week, home-based, smartphone-based PR and educational program on exercise capacity,
QoL, and symptom management in patients. A mobile health care application (Smart Aftercare)
for cellphones was used to provide exercise information to participants. Aerobic exercises were
prescribed for at least three days a week, 30-60 minutes a day. Strengthening exercises were
prescribed once a day for 30 minutes, consisting of exercises for all major muscle groups in the
limbs and trunk. The patients were instructed to run the app and wear an activity measuring
device during workouts. A clinical nurse specialist provided counseling services to patients
through the app. The app also provided information on pain control, nutritional support, and
symptom management. The researchers deemed this intervention feasible and effective, as 90 of
100 (90%) participants completed the 12-week PR program. Anxiety among participants
significantly improved by 12 weeks (baseline: 3.9 [SD 4.1], 6 weeks: 3.4 [SD 3.7, p=0.11], 12
weeks: 2.4 [SD 3.8, p<.001]). Depression worsened by 6 weeks (baseline: 4.7 [SD 4.9], 6 weeks:
5.0 [SD 5.2, p=0.44]), but significantly improved by the end of 12 weeks (3.5 [SD 4.5, p=0.02).
The 6-minute walk distance significantly improved through week 12 (p<0.01) and dyspnea
scores significantly improved in patients with a stable tumor response (p=0.07). Role scores
(p=0.02), emotional scores (p<0.001), and social functioning scores (p=0.002) significantly
improved after the PR intervention. Symptoms including fatigue (p<0.001) and anorexia
(p=0.048) significantly improved as well.
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Multimodal PA Interventions
Two studies implemented exercise programs that included strength training, endurance
training, stretching, and relaxation (Quist et al., 2015; Quist et al., 2020), one study implemented
strength training, endurance training, education, and counseling (Sommer et al., 2018), and one
study implemented strength training, endurance training, Tia Chi, and education (Lu et al.,
2020). The cohort study by Quist and colleagues (2015) aimed to measure the benefits of a
multimodal group exercise intervention on aerobic capacity, HRQoL, muscle strength, anxiety,
and depression. The 6-week program was supervised, and each training session included warmup
exercises, strength training, cardiovascular training, and stretching exercises. Participants
completed the training twice a week for 90-minutes each session. After each training session, 1520 minutes of progressive relaxation was performed. Of the patients (n=114) who completed
baseline testing, 43 dropped out (37.7%) and did not perform the 6-week test point. The
researchers considered this program to be feasible. Results showed that there was a statistically
significant reduction in anxiety scores at post-intervention (median score, -0.9 [95% CI, -1.55 to
-0.25]), but no significant reduction in depression scores was noted. Significant improvements
were reported for VO2 peak (P<.001), 6-minute walk distance (p<.001), muscle strength
measurements (p<.05), and emotional well-being (p<0.0001).
Using an RCT design, Quist and colleagues (2020) conducted a 12-week physical
exercise intervention to evaluate the effects of this program on VO2 peak, 1 repetition maximum
(1RM) strength, functional capacity, HRQoL, anxiety, and depression in participants. This
intervention consisted of supervised, structured cardio and strength training twice a week for 90
minutes in a group of 10-12 participants. After each session, 15-20 minutes of progressive
relaxation training took place. The control group received usual treatment as prescribed and were
16

recommended to stay active during their chemotherapy treatments. Among the 687 eligible
patients, 218 were included in the program, with 110 participants being allocated to the
intervention group and 108 to the control group. Sixty-six participants (60%) from the
intervention group were assessed at 12 weeks, and 67 participants (62%) from the control group
were assessed at 12 weeks. Mean adherence to the 24 sessions attended was 44%. There was a
significant reduction in anxiety (mean difference, -1.1 [95% CI, -2.1 to -0.1]) and depression
(mean difference, -1.3 [95% CI, -2.4 to -0.2]) between the control group and intervention group
at 12-weeks. There were also statistically significant improvements in social well-being (p=0.04)
and muscle strength, which included leg press (p=0.01), leg extension (p<0.01), lateral pull down
(p=0.04), and chest press (p<0.01). The feasibility of this program was shown previously in the
study by Quist and colleagues (2015).
The 4-arm, randomized feasibility study by Sommer and colleagues (2018) evaluated the
safety and feasibility of a rehabilitation exercise program in an outpatient setting and reported
health-related quality of life (HRQoL) changes before and 1 year after surgery. The study
allocated participants into four groups: 1) preoperative (pre-op) and postoperative (post-op)
exercise started two weeks after surgery, 2) pre-op and post-op exercise started six weeks after
surgery, 3) post-op exercise started two weeks after surgery, and 4) current standard care, postop exercise started six weeks after surgery. The pre-op intervention consisted of 30 minutes of
endurance training daily until surgery, which ranged from 2-15 days. All participants were
involved in the same post-op PA exercise intervention. The study implemented the 12-week
supervised post-op intervention, where about half of the patients began the exercise intervention
2-weeks post-surgery, while the other half began the intervention 6-weeks post-surgery. The
intervention was comprised of 24 group-based exercise sessions, three individual counseling
17

sessions, and three group-based sessions involving information on health-promoting behavior.
Smoking cessation information, nutritional counseling, and patient education was also offered.
Individually tailored strength exercises and group aerobic training took place twice a week on
non-consecutive days for 60 minutes per session. Follow up telephone calls were provided to
each patient, although it was not stated when and how often they took place. Assessments of the
patients took place at five different time periods: baseline assessments at the time of diagnosis,
an assessment the day before surgery, an assessment 2-14 days after the intervention period
ended, an assessment near 26 weeks after surgery, and a final assessment near 52 weeks after
surgery. A previous study conducted by Sommer and colleagues (2016) indicated that the
postoperative rehabilitation program is safe and feasible. Forty patients started the post-op
exercise intervention, with 11 dropping out before the end of the 12-weeks. Twelve of the 18
patients allocated to pre-op exercises received instructions, and 3 adhered to the daily exercise.
The following results are concluded as a whole from the 29 patients who completed the post-op
intervention, as results were not provided for each arm of the study. Emotional well-being
(p<0.0001), global quality of life (p=0.0032), and mental health (p=0.0004) all had significant
improvements throughout the study. There was a significant reduction in anxiety (p=0.0003) and
depression (p=0.0062) levels during the study period, with the greatest reductions observed at 6
months post-op. When evaluated at the one-year point, anxiety and depression scores had
increased from the 6-month time period.
The final study was conducted by Lu and colleagues (2020), where the researchers
implemented a three-part exercise program and offered additional education to the participants.
The researchers assessed the feasibility and safety of implementing an exercise program in
patients who have recently undergone LC surgery. Secondary outcomes measured included
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physical functioning of patients and patient-reported questionnaires. The researchers utilized a
12-week PA program that combined supervised and home-based exercise interventions. Patients
exercised five times a week, being supervised twice a week in the physical therapy department
comprising of 90-minute sessions. The first part of the supervised portion was resistance training
consisting of 6 different progressive exercises involving major limb movements. Exercises were
conducted in three sets with 8 to 15 repetitions each set. The second part of the supervised
portion consisted of simplified 8-style Tai Chi and natural breathing. The last part consisted of
brisk walking for aerobic training at a pace of 80% of their maximum effort. The other three days
consisted of an unsupervised home-based exercise program, where the patients walked for 20-30
minutes per session. Education was given to patients, including importance and intensity of
exercise, dietary advice, how to manage their symptoms, and how to overcome exercise barriers.
Participants checked in weekly with the therapists to discuss adherence and subsequent
instructions for the following week. Eight of the 17 (47%) participants met feasibility
requirements by attending at least 70% of the scheduled supervised exercise sessions. Five
participants (29.4%) did not attend any supervised exercises after their baseline assessment.
However, 16 of the 17 (94%) completed the post-intervention questionnaire assessment. This
study was not considered feasible by the authors, as there was a low consent rate (17 of 78
eligible participants - 22%) and low adherence rate. Significant improvements were observed in
the 16 participants who completed the post-intervention questionnaire in both anxiety (baseline
37.4 ± 6.8, follow-up 31.3 ± 5.8, p=0.002) and depression scores (baseline 36.0 [32.0-54.0],
follow-up 31.0 [28.0-35.5], p=0.020) from baseline to follow-up. Improvements in respiratory
function were observed, with an increased forced expiratory volume (FEV1) noted (p=0.02).
Significant improvements were also observed in emotional functioning (p=0.012), global
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HRQoL (p=0.018), and sleep quality (PSQI) (p=0.003). A significant decrease in dyspnea
(=0.157) and coughing (p=0.008) was observed as well in participants.
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Table 1
Study Comparison Table
Author

Title/Source

Quist et al.
(2020)

Effects of an
exercise
intervention
for patients
with advanced
inoperable
lung cancer
undergoing
chemotherapy:
A randomized
clinical trial.

Kuehr et
al.
(2014)

Exercise in
patients with
non-small cell
lung cancer.

Study
Design
Comparative
study; RCT

Cohort
Study;
pretestposttest

Purpose

Sample

Method

Interventions

Results

Primary
outcome:
change in
maximal oxygen
uptake (VO2
peak).
Secondary
outcomes:
muscle strength,
functional
capacity, forced
expiratory
volume in 1 s,
HRQoL, anxiety,
and depression.

218 patients with
advanced
inoperable lung
cancer, >18 years
old, has a WHO
performance
status of 0,1,or 2
with stage IIIb-IV
non-small-cell
lung carcinoma
(NSCLC) or
extensive disease
small-cell
carcinoma and
were undergoing
chemotherapy.
110 people INT
group
108 people CON
group
Mean age 64.5.
Location:
Denmark.
40 enrolled (24
males, 16
females), Pts must
have NSCLC
(stages IIa-IV), be
undergoing radio
and/or
chemotherapy,

VO2 peak
(Cardiopulmonary
exercise testing on
a cycle
ergometer); 1 Rep
Max
(Technogym);
functional
capacity (6MWT)
FEV1 (standard
spirometry test);
HRQoL (FACTL); anxiety and
depression
(HADS).

12-week physical
exercise
intervention (INT)
comprising
supervised, group
structured exercise
training (cardio,
strength, stretching,
and relaxation
training) twice
weekly versus a
control group with
usual care (CON).

218 patients randomized,
110 starting the PA
program. 66/110 patients
completed the 12-week
assessment from the
intervention group. Mean
adherence of the 24
sessions was 44%. No
significant difference
between VO2 peaks.
Significant improvement in
muscle strength.
Significant reduction in
anxiety and depression.
Significant difference in
groups for social wellbeing. Program is
considered feasible.

Functional
capacity (6MWT);
maximal
voluntary
isometric
contraction
(HHDM); Quality
of Life [QoL]

8-week consecutive
hospital and homebased combined
endurance and
resistance training
program.
Participants
exercised 5 times a

40 patients started the PA
program, 31/40 (77.5%)
completed post-exercise
assessment (T1) and 22/40
(55%) completed followup assessment (T2). 55%
of participants met
feasibility. Significant.

Primary
outcome:
feasibility
(adequate
adherence)
Secondary
outcomes:
endurance and
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Sommer et
al.
(2018)

Changes in
health-related
quality of life
during
rehabilitation
in patients
with operable
lung cancer: A
feasibility
study
(PROLUCA)

4-arm,
comparative,
randomized
feasibility
study

strength
capacity, QoL,
fatigue and
depression.

BMI >18, and
ability to read
German. Mean
age 60 (22-75).
Location:
Germany.

(FACT-L);
fatigue (MFI);
depression (PHQ9); exercise
program status
(individual
standardized
diary)

week, being
supervised for 3
days a week.
Outpatient
participants
exercised 3 times a
week. Participants
received weekly
follow up phone
calls.

To investigate
the safety and
feasibility of
preop and early
postop rehab in a
nonhospital
setting, focusing
on exercise, in
pts undergoing
surgery for LC.
The aim of the
article is to
present HRQoL
changes over
time before and
1 year after
surgery in the
same population.

40 patients
included (16
males, 24
females). 9(22%)
underwent a
thoracotomy,
31(78%) had
video-assisted
thoracic surgical
resection (VATS),
13 (33%) received
postoperative
(adjuvant)
chemotherapy.
Inclusion –
NSCLC,
scheduled for
surgery with
curative intent,
>18, WHO status
0 to 2, resident of
City of
Copenhagen or
nearby, ability to
read/understand

HRQoL (EORTCQLQ-C30 & the
FACT-L scale);
general well-being
(SF-36 form);
anxiety and
depression
(HADS); distress
(NCCN Distress
Thermometer);
social support
(MSPSS).

Pre-op endurance
training daily until
surgery (2-15
days). Post-op,
individually
tailored, supervised
strength and
cardiorespiratory
exercise twice a
week (60
min/session) on
nonconsecutive
days for 12 weeks
(total 24 sessions).
3 individual
counseling sessions
and 3 group-based
lessons in health promoting behavior
were included.
HRQoL was
assessed 5 times: at
diagnosis, day
before surgery, 214 days after last
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improvement in the 6minute walk distance and
in knee, elbow, and hip
muscle strength after the
intervention T1. No
significance for QoL,
fatigue, and depression
scores - remained stable or
declined slightly.
Significant improvements
in knee-muscle strength
were also observed at T2.
Program is considered
feasible.
18 patients allocated to the
pre-op intervention, 3
adhered to daily exercise.
40 patients started the postop PA program, 11/40
patients dropped out,
including 3 due to side
effects of chemo. Post-op
adherence was >70% in
15/29 patients. Global
quality of life, mental
health, and emotional wellbeing had a statistically
significant improvement
throughout the study.
Statistically significant
reductions in anxiety,
depression, and distress,
with greatest reduction
found at 26 weeks after
surgery. Program is
considered feasible
(Sommer et al., 2016).

Danish, and
approval by
primary surgeon.
Mean age 68.
Location:
Denmark.

exercise
intervention, 26
weeks after
surgery, and 52
weeks after
surgery.

Park et al.
(2019)

Mobile phone
app-based
pulmonary
rehabilitation
for
chemotherapytreated patients
with advanced
lung cancer:
Pilot study

Cohort
study;
pretestposttest

To investigate
the feasibility
and efficacy of a
smartphone appbased pulmonary
rehabilitation
and educational
program on
exercise
capacity,
symptom
management,
and QoL in
patients with
NSCLC
undergoing
chemotherapy.

100 patients
enrolled (46
males, 54
females). Patients
undergoing
chemotherapy,
aged 20-75 years
(mean age 55.1),
had NSCLC stage
II-IV, ECOG-PS
score of 0-2, and
had an android
smartphone.
Location: South
Korea.

Endurance
(6MWT);
Strength (arm
abduction test);
QoL (EORTC
QLQ-C30); pain
(NRS); anxiety
(GAD-7);
depression (PHQ9).

Quist et al.
(2015)

The impact of
a
multidimensio
nal exercise
intervention on
physical and
functional
capacity,

Cohort
study;
pretestposttest

To investigate
the benefits of a
6-week
supervised group
exercise
intervention and
to determine the
effect on aerobic

114 included (57
males, 57
females). Subjects
are over 18, WHO
status of 0-2,
stage IIIb-IV
NSCLC and
SCLC-ED, and

Aerobic capacity,
muscle strength,
& functional
capacity
(6MWD); FEV1
(spirometer);
HRQoL and
cancer-related
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12-week
pulmonary rehab
program. Exercise
prescribed once a
day for 30-60 min.
at least 3 days a
week, a walking
distance target of
60-80% of the
6MWT, and
strength once a day
for 30 min.
Counseling, pain
control nutritional
support, and
symptom
management
services were
provided through
the app.
6-week program,
supervised group
training (physical
training and
relaxation) carried
out in group 10-12
patients twice
weekly. Each

100 patients started the 12week rehab program, with
90/100 participants
completing it. 6MWD had
significant improvement.
No significant
improvement in patients
overall. Emotional and
social functioning had
significant improvements.
Fatigue, anorexia, and
diarrhea showed significant
improvements. Depression
and anxiety had significant
improvements. No
significant change in QoL
or severity of pain.

369 eligible participants,
114 started PA program.
71/114 patients (62%)
completed training and
offered results. Significant
increase in aerobic
capacity, VO2peak, and
functional capacity.

anxiety, and
depression in
patients with
advancedstage lung
cancer
undergoing
chemotherapy.

Comparative
study; RCT

capacity,
strength,
HRQoL, anxiety,
and depression.

were undergoing
chemotherapy.
Mean age 66 (3188). Location:
Denmark.

symptoms
(FACT-General
and FACT-L);
anxiety and
depression
(HADS).

session was 1.5
hours. Sessions
included warmup,
strength and fitness
training, stretching,
and relaxation.

Primary
outcome:
exercise capacity
Secondary
outcomes: PA
and sedentary
behavior,
peripheral
muscle force,
HRQoL, fatigue,
feelings of
anxiety and
depression, and
lung function.

17 participants
were included (5
males, 12
females); 9 in
exercise groups
and 8 in control
groups. Inclusion
was people 6-10
weeks after
lobectomy for
NSCLC (stages IIIIA), or for
patients who
required post-op
chemotherapy 4-8
weeks after their
last cycle. Mean
age 67. Location:
Australia.
9 patients initially
enrolled. 6
participants (5
males, 1 female)
completed the
study Participants
were undergoing
chemotherapy,

Exercise capacity
(6MWD);
HRQoL (SF-36,
FACT-L, and
EORTC QLQC30); anxiety and
depression
(HADS); fatigue
(FACIT-Fatigue);
handgrip force
(dynamometer);
PA levels (two
PA monitors).

8-week program
aimed at improving
aerobic capacity
and muscle
strength. Included
individualized
training 3X per
week, lasting 60
min each. Each
class comprised
aerobic and
resistance training.
Control group
received no
exercise training.

Physical activity
and step count
(Uniaxial
accelerometry
monitor
[Lifecoder EX]);
psychological
adjustment -

Each patient was
instructed to wear
the step counter
during the day. For
week 1, each
participant was
instructed to live
normally. After

Cavalheri
et al.
(2017)

Exercise
training for
people
following
curative intent
treatment for
non-small cell
lung cancer: A
randomized
controlled trial

Arai et al.
(2010)

Physical
Cohort Study; 1) To examine the
activity and
pretestfeasibility of the
psychological
posttest
PA intervention
adjustment in
program
Japanese
2) examine the
advanced lung
change in
cancer patients
patient’s PA and
in
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Significant improvement in
strength. Significant
reduction in anxiety score.
No significant reduction in
depression. Significant
decrease in social wellbeing. No significant
improvement in HRQoL,
fatigue, or FACT-L
subscales. Program is
considered feasible.
17 patients enrolled in study,
9 started the PA program.
4/9 participants (44%)
adhered to exercise
training. Significant
increased exercise
capacity. No changes
observed in PA and
sedentary behavior,
peripheral muscle force,
HRQoL, fatigue, feelings
of anxiety and depression,
and lung function.
Researchers suggest PA
programs may be
beneficial for LC patients.

9 patients started the
intervention, 6/9
participants completed the
intervention period (66.6%
completion rate). Results
suggest a PA intervention
program is not feasible.
Psychological adjustment

chemotherapy:
The feasibility
of
intervention.

Olivier et
al.
(2018)

Real-life
Cohort Study;
feasibility of
Pretesthome-based
posttest
pulmonary
rehabilitation
in
chemotherapytreated patients
with thoracic
cancers: A
pilot study

psychological
adjustment
3) examine the
relationship
between PA and
psychological
adjustment in
Japanese
advanced lung
cancer patients in
chemotherapy.

without mental
disease, and
received a rating
of 0-2 on the
Eastern
Cooperative
Oncology Group
Performance
Status. Mean age
61 (48-64).
Location: Japan.

anxiety and
depression
(HADS);
Lung cancer
symptoms
(MDASI-J);
participants
activity level at
week 0
(transtheoretical
model of change).

Primary
outcome:
feasibility and
safety
Secondary
outcomes:
exercise
capacity, lower
limb muscle
strength,
dyspnea, QoL,
anxiety, and
depression.

71 patients started
the home-based
PR (54 males, 17
females). Most
were men in their
60s with a
smoking history
and advanced LC.
All pts treated
with
chemotherapy.
Mean age was
60.1. Location:
France.

Exercise capacity
(6MWT); lower
limb muscle
strength (TUG,
10CS); chronic
dyspnea on
exertion (mMRC
scale); QoL
(VSRQ); anxiety
and depression
(HADS).
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this, an
intervention was
given to each
participant to
enhance their PA.
This occurred
again after week 2,
and then again after
week 4. Data from
the step-counters
were collected
throughout the
entirety of the
study.
Independent, home
based 8-week
program, 5 days
per week. Each day
lasted 30-45 min
and included
endurance training
on cycle ergometer
and muscle
strengthening
exercises.
Resumption of
daily physical
activities,
therapeutic
education,
psychological
counseling,
motivational
communication,
and nutritional
advice was
implemented.

did not change at any time
during the study. No
significant changes with
anxiety or depression.

243 eligible participants,
71 started the PA program.
24 patients did not
complete program. 47/71
(66%) finished the
program. Significant
decrease in anxiety. No
significant decrease in
depression. 6MWT
stability and 6MST
improvement. Daily PA
was significantly
improved. No significant
decrease in dyspnea scores
and in lower limb muscle
tiredness. QoL
improvement was not
significant.

Lu et al.
(2020)

A 12-week Cohort study;
multi-modal
pretestexercise
posttest
program:
Feasibility of
combined
exercise and
simplified 8style Tai Chi
following lung
cancer surgery.

Primary
outcome:
feasibility and
safety.
Secondary
outcomes:
measurements of
physical function
and patientreported
questionnaires.

78 patients with
stage I-IIIA
NSCLC at 6-12
weeks following
completion of
treatment were
approached, 17
consented (5
males, 12
females). Mean
age was 59 (4463). Conducted at
a tertiary hospital
in Nantong,
China.
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Physical function
(6MWT and Short
Physical
Performance
Battery [SPPB]);
PA levels
(electronic
pedometer); mood
(Self-rated
Anxiety Scale
[SAS] and the
Self-rating
Depression Scale
[SDS]); HRQoL
(EORTC-QLQC30 and LC13);
symptoms
(MDASI-T); sleep
(PSQI).

12-week program,
supervised exercise
2X per week in PT
department, 90minute sessions,
and exercise at
home for 3X per
week. 3 parts
exercise
intervention:
resistance training,
simplified 8-style
Tai Chi, & aerobic
exercise (brisk
walking).
Home program
included walking at
home 20-30
minutes a week on
non-supervised
exercise days.
Education about
exercise and
dietary advice was
given. Exercises
were individually
tailored each week.

78 eligible participants,
with 17 consenting to
study. 16/17 participants
completed the postintervention follow-up
questionnaire (94%). 47%
(8/17) attended at least
70% of scheduled
supervised sessions –
feasibility is not supported.
3 minor adverse events
occurred; no serious
adverse events reported.
Significant improvement in
FEV1. Significant
improvement in HRQoL.
Significant reduction in
anxiety and depression. No
significant improvement in
functional capacity or PA
levels.

Notations
RCT – randomized control trial
HRQoL – health related quality of life
1 Rep Max – 1 repetition maximum
FEV1 – forced expiratory volume in 1 second
CON – control group
PA – physical activity
NSCLC – non-small-cell lung carcinoma
BMI – body mass index
MFI - multidimensional fatigue inventory
LC – lung cancer
EORTC - European Organization for Research and Treatment in Cancer
SF-36 – Short Form Health Survey
MSPSS - Multidimensional Scale of Perceived Social Support
Post-op – post operation
NRS – numeric rating scale
6MWD – 6-minute walk distance
FACIT-Fatigue – Functional Assessment of Chronic Illness Therapy – Fatigue
subscale
TUG – timed Up and Go Test
mMRC - Modified Medical Research Council dyspnea scale
SPPB - Short Physical Performance Battery
SDS – Self-rating Depression Scale
PSQI - Pittsburgh Sleep Quality Index

VO2 – maximal oxygen uptake
WHO – World Health Organization
6MWT – 6-meter walk test
INT – intervention group
FACT-L – functional assessment of cancer therapy – lung
HADS – Hospital Administered Anxiety and Depression Scale
QoL – quality of life
HHDM - handheld dynamometry
PHQ-9 - patient health questionnaire
VATS - video-assisted thoracic surgical resection
QLQ – Quality of Life Questionnaire
NCCN - National Comprehensive Cancer Network
Pre-op – pre operation
ECOG-PS - Eastern Cooperative Oncology Group-Performance Status
GAD-7 – generalized anxiety disorder-7
SCLC-ED – extensive stage disease small cell lung cancer
MDASI-J – Japanese version of the M.D. Anderson Symptom Scale
10CS – 10 chair stands
VSRQ - Visual simplified respiratory questionnaire
SAS – Self-rating Anxiety Scale
LC13 – lung cancer module
MDASI-T – Taiwanese version of the M.D. Anderson Symptom Scale
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DISCUSSION

This review examines the literature published within the last 10 years regarding the
effects of PA on depression and anxiety in people with lung cancer undergoing treatment. The
findings from this literature review indicate that implementing PA programs is feasible in this
population to decrease anxiety and depression. Feasibility was defined in these studies as
participants adhering to the PA programs, which included consenting to the study and/or
completing a certain amount of intervention sessions. A majority of the studies (six) reported
their interventions as being feasible (Cavalheri et al., 2017; Kuehr et al., 2014; Olivier et al.,
2018; Park et al., 2019; Quist et al., 2015; Quist et al., 2020; Sommer et al., 2018), 2 of the
studies reported PA intervention programs as not being feasible (Arai et al., 2010; Lu et al.,
2020), and Cavalheri and colleagues (2017) suggested LC patients undergoing curative treatment
may benefit from PA programs. The study by Lu and colleagues (2020) reported that their study
was not considered feasible due to the low consent and adherence rate, even though their PA
program significantly reduced anxiety and depression. The study did have participants exercise
five times a week, ranging from 20-90 minutes, and did implement a three-part exercise
intervention. The perceived large amounts of exercise may have contributed to participants not
wanting to join and/or adhere to these study conditions. Implementing a less-extensive exercise
intervention therefor may be more feasible, as other studies with successful results implemented
less-frequent and shorter-duration workouts.
The studies that had the lowest dropout rates included the studies conducted by Park and
colleagues (2019), Kuehr and colleagues (2014), and Sommer and colleagues (2018). While
these three studies all had over a 70% completion rate, two of the studies did not offer
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adherence/feasibility rates (Park et al., 2019; Sommer et al., 2018). The study by Kuehr and
colleagues (2014) did offer a feasibility rate, stating that only 55% of participants met the
feasibility requirements of attending a certain amount of intervention sessions. Only four studies
overall offered the number of participants meeting adherence rates, which ranged between 44%
to 55% of participants (Cavalheri et al., 2017; Kuehr et al., 2014; Lu et al., 2020; Quist et al.,
2020). It is hard to determine which PA intervention programs actually had the highest
attendance rate of participants throughout the entirety of the studies since not all studies provided
the adherence rates and/or number of participants who met feasibility requirements. Each study
also had their own guidelines for meeting adherence and feasibility. The interventions used in
each study were all found to be safe, as no serious adverse events were reported by any of the
researchers. However, Lu and colleagues (2020) did report three minor adverse events occurring
throughout their intervention period.
While three studies show no evidence of PA interventions improving anxiety and/or
depression (Arai et al., 2010; Cavalheri et al., 2017; Kuehr et al., 2014), six studies provide
evidence of a PA program improving anxiety (Olivier et al., 2018; Quist et al., 2015), and four of
those studies provide evidence of a PA program improving both anxiety and depression (Lu et
al., 2020; Park et al., 2019; Quist et al., 2020; Sommer et al., 2018).
The findings suggest that a PA program is beneficial at reducing anxiety and depression
in this population when meeting certain criteria—at least 12 weeks in length and implementing a
multimodal PA intervention. The results show that any unimodal intervention was not effective
in reducing anxiety and/or depression (Arai et al., 2010; Cavalheri et al., 2017; Kuehr et al.,
2014). Each of these studies only implemented one type of intervention, including only support
and encouragement to improve PA levels (Arai et al., 2010), or only a strength and endurance
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exercise program (Cavalheri et al., 2017; Kuehr et al., 2014). These three studies did however
have small sample sizes and used intervention periods of eight weeks or less. The other six
multimodal intervention studies implemented a PA intervention, as well as a psychological
and/or health promoting intervention, which included therapy, education, counseling,
motivational communication, nutritional advice, relaxation, health promotion, and/or symptom
management (Lu et al., 2020; Olivier et al., 2018; Park et al., 2019; Quist et al., 2015; Quist et
al., 2020; Sommer et al., 2018). All six of these studies’ intervention were associated with
significantly reduced anxiety in people with lung cancer, however, only four of the studies
reduced both anxiety and depression (Lu et al., 2020; Park et al., 2020; Quist et al., 2020;
Sommer et al., 2018).
The key difference found in these studies that affected both anxiety and depression was
the length of the intervention period. The four studies that significantly reduced anxiety and
depression scores implemented a 12-week intervention (Lu et al., 2020; park et al., 2020; Quist
et al., 2020; Sommer et al., 2018), while the two other studies that only reduced anxiety
implemented a 6-week intervention (Quist et al., 2015) and an 8-week intervention (Olivier et al.,
2018). To further support this, the two studies conducted by Quist and colleagues (2015) and
Quist and colleagues (2020) implemented a near-identical intervention, with the length of
intervention being the major difference. The study by Quist and colleagues (2015) only
implemented the intervention for six weeks and found a significant reduction in anxiety, but not
depression. In contrast, the study by Quist and colleagues (2020) implemented nearly the same
intervention for 12 weeks and found a significant reduction in both anxiety and depression. This
suggests that long-term exercise may be more beneficial than temporary PA programs.
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An interesting finding presented by two studies is an increase in depression near 6-8
weeks after an intervention began (Kuehr et al., 2014; Park et al., 2019). The study by Kuehr and
colleagues (2014) showed a slight, non-statistically significant increase in depression by the end
of the 8-week intervention, but then had a decrease in depression when evaluated eight weeks
after the end of the intervention. The study by Park and colleagues (2019) also showed
depression worsening by six weeks after the start of the intervnetion, but then significantly
improving by the end of the intervention at 12 weeks. These findings further support that the
criteria of an effective intervention should be at least 12 weeks in length when targeting
depression.
While not all of the studies were effective in reducing both anxiety and depression, the
interventions implemented were found to have other significant positive effects on the
participants, including improved PA levels, strength, emotional and social well-being, cancerrelated symptoms, and/or quality of life (Cavalheri et al., 2017; Kuehr et al., 2014; Lu et al.,
2020; Olivier et al., 2018; Park et al., 2019; Quist et al., 2015; Quist et al., 2020; Sommer et al.,
2018). The results show that exercise can be beneficial in other aspects of health and that some
exercise may be better than none, as one study used shorter 30-45-minute exercise intervals and
had significantly reduced anxiety in participants (Olivier et al., 2018). However, this study did
implement other interventions in their study as well, and none of the exercise-only interventions
were effective in reducing anxiety and/or depression (Cavalheri et al., 2017; Kuehr et al., 2014).
Limitations of the studies that may affect the results include a high drop-out rate of
greater than 30% in a majority of the studies and low sample sizes (<50 participants) in over half
of the studies. High dropout rates and small sample sizes may result in a reduced probability that
the significant results can be generalized. Both of these limitations may lead to biases, such as

31

toward people who liked to exercise prior to LC. Each of the studies, with the exception of the
studies by Quist and colleagues (2015) and Quist and colleagues (2020), uses a different PA
intervention as well. This may also cause a limitation of knowing which programs actually work
best. However, it does show that multiple different types of interventions are effective, meaning
if one type of program doesn’t work for a particular patient, another type of intervention might
be beneficial.
There does not appear to be a difference in outcomes between PA interventions that were
supervised vs. unsupervised, group-exercises vs. individualized exercises, or home-based
settings vs. inpatient/outpatient settings. There also does not appear to be a difference in
outcomes when comparing the amount of exercise participants engaged in while completing the
intervention periods. Successful interventions ranged from exercising 120 minutes a week to up
to 390 minutes a week.
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IMPLICATIONS

The implications of this review present recommendations for nurses to implement in
clinical practice and recommendations for further research regarding PA in people with lung
cancer undergoing treatment.
Recommendations for Clinical Practice
Nurses should first screen patients at baseline for past and present anxiety and depression,
their current activity levels, and their willingness for engaging in PA. Nurses can help patients
find a good starting point on a multimodal PA program based on their assessment. Starting all
patients on a PA program is recommended even if they are not experiencing anxiety and
depression symptoms, or if they are already taking medications for these symptoms. Doing so
may help prevent developing and/or worsening anxiety and depression levels while also
providing many other health benefits.
Nurses should then have a discussion with patients and educate them on PA and how it
can be an effective long-term strategy to reduce anxiety and depression. When discussing PA
programs with patients, patients should be involved as much as possible in creating a program
and schedule. Nurses can use these findings to promote PA in their patients with lung cancer or
encourage them to find a formal activity program that meets the several recommendations from
this review. In either situation, in order to help patients reduce their anxiety and depression, PA
programs should combine endurance and resistance training, along with at least one other
psychological/health promoting strategy. Programs should be at least 12 weeks in length or
longer, and patients should be encouraged to be active as much as possible. If patients don’t want
or can’t adhere to a program that has them exercising five days a week, then starting them on a
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program that implements PA exercises 2-3 times a week would be more practical and might be
easier for them to adhere to. Some patients may not be able to tolerate long exercise periods, so
starting them on shorter exercise periods, such as 20-minute workout intervals, and then
increasing the length of workouts each week may be beneficial for the patient to meet the
recommended guidelines. The recommendations of the U.S. Department of Health and Human
Services (HHS) (2018) and World Health Organization (WHO) (2020) both recommend 150-300
minutes of moderate-intensity PA per week for adults, including cancer survivors. They state this
population should gradually increase activity as tolerated and should aim to engage in more than
the recommended activity levels (when not contraindicated) to avoid the harmful effects of a
sedentary lifestyle (WHO, 2020).
Additional psychological/health promoting strategies that nurses should recommend
include therapy, counseling, education, nutritional advice, motivational communication,
relaxation, and/or symptom management. Since there isn’t enough evidence that supports which
intervention is best when used alongside PA, nurses can offer any of these additional
interventions to patients depending on what they are interested in and have access too. Nurses
can refer clients to personal trainers or physical therapists, find a program online and provide it
to the patient, or use a smartphone-based application to guide the patient in PA. While not
everyone has convenient access to the supplemental therapies such as therapists, counselors, or
dieticians, nurses can also use and recommend smartphone-based applications and internet
services that involve teachings and demonstrations of psychological/health promoting
interventions.
Nurses should discuss with patients whether home-based settings or outpatient settings
better fit their needs, as well as group-training sessions vs independent training sessions. The
34

variety of settings that can be used increases patients’ autonomy and allows them to be included
in determining what type of program best fits their needs, such as their personalities, desires, and
financial situation. This may increase their adherence to their PA programs and outcomes as they
get to choose what they like.
Evaluating patients’ levels of anxiety and depression throughout treatment is important as
well to determine if the current PA exercises and supplemental psychological/health promoting
interventions are effectively reducing symptoms. If it is found that the patient isn’t having
reduced symptoms, nurses should suggest a change or implement additional supplemental
psychological/health promoting interventions or have them do additional physical activities.
Nurses should also assess the need for medication if the patients aren’t seeing any significant
improvements in their anxiety and depression and/or if they are not on any medications already.
Nurses should also evaluate if the patients are adhering to their programs.
Recommendations for Research
Further research must be conducted to evaluate if additional interventions such as
psychological or health promoting interventions are necessary in conjunction with exercise
interventions. Further research using exercise-only PA programs needs to be conducted using
longer intervention periods of at least 12 weeks, with much larger sample sizes to evaluate if
exercise alone is feasible and if engaging in some exercise is better than none. This research
should also include measuring anxiety and depression in participants well after the intervention
has completed, such as 12-weeks post intervention. In future studies, cardio-only exercises, such
as walking, biking, hiking, or swimming, or resistance-training-only exercises, such as
weightlifting, should be implemented to determine if one type of exercise is beneficial, which

35

one is more beneficial (if any), or if participants must engage in both types of exercise to reduce
anxiety and depression.
Additional research is also needed to determine the best type of supplemental
psychological/health promoting interventions to be used alongside exercise or independently
when targeting anxiety and depression in this population. Future studies should implement the
same PA exercise program in a large sample size study and consider conducting multi-arm
clinical trials to determine which supplemental interventions best complement the PA program.
Further research must also be conducted to determine how to increase exercise
adherence. Future studies may consider comparing PA programs among participants exercising
two times a week to participants exercising four times a week, attempting to use very similar
exercise routines. This will help determine if PA programs with less frequent exercise have a
greater adherence rate or vice versa. Multi-arm clinical trials should also be considered for
conducting future studies with very similar PA programs to compare home-based settings to
outpatient settings and individualized training to group training sessions. This can help determine
which types of programs have the greatest adherence rates among participants.
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CONCLUSION

This review is intended to provide nurses with insight regarding whether implementing a
PA program in people with lung cancer undergoing treatment is effective and feasible in
reducing anxiety and depression, and if so, what kind of PA program is best. A PA program that
is at least 12 weeks in length, includes strength and cardio exercises, and implements other
psychological and/or health promoting interventions was found to be most effective. Further
research is needed to determine if exercise-only PA programs are feasible, which additional
interventions best compliment PA programs, and how to increase adherence rates among
participants. Nurses should promptly recommend long-term multimodal PA interventions that
consists of endurance training, resistance training, and at least one supplemental
psychological/health promoting intervention to all people with lung cancer to help reduce or
prevent these symptoms from occurring during and after lung cancer treatment.
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